Donald Trump & Eli Lilly and Company
17 shared events · Importance 7 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
Donald Trump: Donald Trump's comments about a potential end to the Middle East conflict influenced market sentiment, leading to speculation about peace.
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Apr 01, 2026 · 14 articles
Domestic
Donald Trump: Donald Trump announced new tariffs on various imported goods, aiming to boost domestic manufacturing and reduce the budget deficit, despite warnings of increased inflation and harm to consumers.
Eli Lilly and Company: Eli Lilly and Company, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
International
Donald Trump: Donald Trump's warnings and threats against Iran contributed to escalating geopolitical tensions and rising oil prices.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Jun 03, 2026 · 191 articles
Domestic
Donald Trump: President Donald Trump has expressed little anxiety about AI displacing human workers, focusing instead on AI-related investments driving economic growth and job availability.
Eli Lilly and Company: Eli Lilly is an employer involved in the RaiseMe project, contributing to the nonprofit's goal of adapting the workforce to an AI economy.
Jun 25, 2026 · 7 articles
Regulatory
Eli Lilly and Company: Eli Lilly and Company agreed to lower prices for its obesity drug Zepbound and will sell a starter dose for $299 a month, with additional doses up to $449, representing $50 reductions from current direct-to-patient prices. Its sales of Zepbound have tripled this year to over $9 billion.
Nov 06, 2025 · 6 articles
Domestic
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
Business
Eli Lilly and Company: Eli Lilly and Company faces increased competition with Novo Nordisk's Wegovy pill launch, potentially impacting its market dominance in weight-loss drugs. Its shares fell following the announcement.
Jan 05, 2026 · 7 articles
NEWSDESK
Explore this relationship live
Track how Donald Trump and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard